✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Tyche Industries Ltd.

TYCHE

Market Cap
₹148 Cr.
P/E
22.02

Tyche Industries Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
148 Cr
PE
PE
22.02
Prom Holding
Prom Holding
61.97 %
ROE (%)
ROE (%)
9.08
ROCE (%)
ROCE (%)
12.13
Div Yield (%)
Div Yield (%)
2.08
Sales
Sales
49.80 Cr
OPM (%)
OPM (%)
5.49 %
Debt to Equity
Debt to Equity
-
Institutions
Institutions
-
Individual < 2 lac
Individual < 2 lac
21.78 %
No. of Shareholders
No. of Shareholders
6,952
View more
Edit Ratio's

About

Tyche Industries Ltd, initially a software company, diversified into the production of fine ch… Read more
Low
99
52W Range
High
154
  • Tyche Inds
  • Smruthi Organics
  • Bal Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • Advertisement Spend as a % of Total Sales (%)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Tyche Industries Ltd. Business

    Tyche Industries Ltd started as a software company and later expanded into manufacturing fine chemicals. They specialize in API's, Intermediates, Nutraceuticals, Fine and Specialty Chemicals through Custom Synthesis/Contract/Toll Manufacturing and Research & Development.

    Tyche Inds major competitors are Smruthi Organics, Bal Pharma, Mangalam Drugs&Org., Everest Organics, Lasa Supergenerics, Nectar Lifesciences, Haleos Labs.
    Market Cap of Tyche Inds is ₹138 Crs.
    While the median market cap of its peers are ₹138 Crs.

    Tyche Inds seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Jun
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Tyche Industries Ltd.
    View the discussion on ValuePickr
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material